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Abstract
Background: Gynecological cancer is one of the most common reproductive health
problems of cancer. Factors that cause high rates of the incidence of gynecological
cancer, because many symptoms are ignored so that symptoms that can actually be
treated early become a very serious disease. Women with gynecological cancer have
a burden of symptoms over time which can cause a negative response to the patient’s
physical, psychological and emotional. Objectives: This study aimed to describe the
symptom burden in women with gynecological cancer. Methods: This study used
quantitative and descriptive research using cross sectional approach. Conducted in
May 2019, with 95 subjects research at Rumah Singgah in Bandung using convenience
sampling. Symptom Burden was assessed using Memorial Symptom Assessment
Scale (MSAS). Resuts: Ten common symptoms experienced by respondents with
gynecological cancer were worrying 96.8% (92), feeling sad 95.8% (91), insomnia
93.7% (89), problems with activity or sexual arousal 89, 5% (85), feeling tired 86.3%
(82), lack of appetite 81.1% (77), dizziness 80% (76), irritability 80% (76), pain 78.9%
(75), less energy 78.9 (75), with a symptom mean of 1.08 (± 0.386). Conclusion:
Indicated that psychological symptoms is the common symptom that experienced
by women with gynecological cancer. Nursing and other healthcare professional is
expected to paymore attention to psychological symptoms tomeets the need of patient.
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1. Introduction
World Health Organization (WHO) states that the reproductive health rate of women in
developing countries reaches 36% calculated from the total burden of illness suffered
during the productive period [1].
Gynecological cancer is one of the reproductive health problems that often occurs.
WHO states that in 2030 it is predicted that an increase in the incidence of ovarian
cancer sufferers by as much as 70% is in developing countries, including Indonesia
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[2]. Based on the 2012 Global Burden of Cancer estimate, the International Agency for
Research on Cancer (IARC), cervical cancer and ovarian cancer are the most common
gynecological cancers in Indonesia. The incidence of cervical cancer is 17.3% per
100,000 women per year and ovarian cancer at 8.4% per 100,000 women per year
[3].
Ovarian cancer is one of the gynecologic malignancies that causes death, based on
data obtained from the Darmais Cancer Hospital in Indonesia in 2013, there were 46
people died of ovarian cancer and there were 134 new cases of women with ovarian
cancer [4].
Cervical cancer is a case of malignancy that mostly attacks women throughout the
world and ranks third in the world in terms of malignancy that attacks women. In
developing countries including Indonesia, in 2002 there were 80% of cervical cancers
causing death while in 2008 around 88% and possibly in 2030 will increase to 98%
[1]. Common symptoms caused by cervical cancer sufferers, namely the emergence of
pain and bleeding during sexual intercourse, excessive vaginal discharge and abnormal
bleeding outside the menstrual cycle [2].
Symptom burden can be defined as the prevalence of the frequency, and the severity
of symptoms are subjective and quantitative, that puts a burden on the patient physio-
logical and can produce negative response on the physical, psychological, and patients
emotions [5]. Womenwith cancer gynecology having symptom burden from time to time,
some data showing that fatigue, limited cognitive, depression, anxiety, trouble sleeping,
pain and trouble having sexual intercourse that lasts for the therapeutic process [6].
Apart from the various types of gynecological cancers that occur, patients with
gynecological cancer are a common problem and have the highest number of symptoms
among all cancer groups [7]. Symptom burden analysis of a disease is carried out aimed
at measuring the combined impact of fatal burdens that cause death and non-fatal
burdens which are detrimental to [6].
Previous research has focused on the symptom burden that arises after the process
of chemotherapy in patients with gynecological cancer, the symptom burden that is
seen when diagnosed with gynecological cancer-related diseases is rarely noticed. In
Indonesia no one has examined the symptom burden related to gynecological cancer,
while the symptom burden in gynecological cancer is important to note because symp-
toms that cause distress can reduce the quality of life of patients and cause difficulties in
daily activities. This research will look at the symptom burden in gynecological cancers
both those who have done the chemotherapy process and those who have not yet
done the chemotherapy process.
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2. Methods
This research is a descriptive research with cross-sectional approach. The research was
carried out in shelter home Bandung, on May to June 2019. Population was patients with
cancer gynecology residing in a stop in Bandung. Convenience of sampling was used
to recruit sample with inclusion criteria women > 18 years with cancer gynecology and
understand Indonesian Language. Exclusion criteria is women with cancer gynecology
who has mental disorders. Estimation sample size calculated use of software g-power
version 3.1.9.2 use exact – Proportion: Difference from constant (binomial test, one
sample case) assuming α = 0.05 effect size = 0.15 power level = 0.95 constant proportion
0.65, results 95 sample size. An instrument used in this research was The Memorial
Symptom Assessment Scale (MSAS) developed by portenoy in 1994 with Cronbach α
= 0,88 and 0,83. MSAS developed is an instrument to inform multidimensional (The
presence of symptoms, frequency, intensity, distress related symptoms).
MSAS of Indonesian version have been adopted and been validated by Haryani (2018)
without change of original version for measuring prevalence of symptoms, characteristic
and distress. Be translatable in through two procedure consisting of translation forward-
backward and validation done [8]. The process of validation pre-test involving terminal
patient, 34 psychometrics MSAS and examination of Indonesian version (207) MSAS-
I involving terminal patient. Internal consistency, repeated reliability, construct, and
validity of is same MSAS-I. Alpha the cronbach to scale total MSAS-I ranged from 0,75
to 0,87. The validity Cronbach α to scale the total and MSAS-I = 0,75-0,87.To test the
reliability = - 0,80 0,89. MSAS-I provides a valid and it can be used to judge frequency
symptoms, severity, and distress of patients with cancer
3. Results
The result shows that more than half of respondents with gynecological cancer aged
40-60 years 63.2% (60) with an average age of 44.0 (± 7.87) The highest education
level of respondents is elementary school of 51, 6% (49), then at the SMP level 32.6%
(31) and SMA 15.8% (15). The majority of respondents’ work is IRT (Housewife) at 90.5%
(86) and all respondents in this study were married (100%). The most common types
of cancer experienced by respondents were cervical cancer 66.3% (63), then ovarian
cancer 29.5% (28) and endometrial cancer 4.2% (4). Around 46.3% (44) respondents
were in stage III and 63.2% (60) respondents were in the process of chemotherapy.
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Table 1: Ten Most Frequent Symptoms Burden.
Symptom Prevalence
% (n)
Frequency % Severity % Burden %
1 2 3 4 1 2 3 4 0 1 2 3 4
Pain 78.9 (75) 40.0 22.1 10.5 6.3 36.8 34.7 4.2 3.2 45.2 17.9 6.3 3.2 6.3
Lack of
energy
78.9 (75) 43.2 32.6 2.0 1.1 51.6 21.1 3.2 3.0 57.8 10.5 4.2 1.1 5.3
Fatigue 86.3 (82) 50.5 32.6 2.1 1.1 37.9 46.3 2.1 - 42.0 26.3 15.8 1.1 1.1
Difficulty
sleeping
93.7 (89) 9.5 45.3 16.8 22.1 8.4 57.9 8.4 18.9 5.4 58.9 4.2 6.3 18.9
Feeling
sad
95.8 (91) 18.9 60.0 15.8 1.1 23.2 70.5 2.1 - 49.4 41.1 3.2 2.1 -






89.5 (85) 1.1 5.3 56.8 26.3 - 38.9 35.9 14.7 - 13.7 35.8 33.7 6.3
Lack of
appetite
81.1 (77) 46.3 15.9 18.9 - 47.4 30.5 3.2 - 50.2 13.7 14.7 3.2 -
Dizziness 80.0 (76) 37.9 29.5 12.6 - 53.6 25.3 1.1 - 30.4 45.3 3.2 1.1 -
Feeling
irritable
80.0 (76) 16.8 47.4 14.7 1.1 36.8 41.1 2.1 - 33.7 44.2 2.1 - -
Based on table 1 above shows that the 10 highest prevalence of symptoms experi-
enced by respondents ranged from 78.9% (76) for pain problems to 96.8% (92) who were
worried. Ten common symptoms experienced by respondents were feeling worried
96.8% (92), feeling sad 95.8% (91), insomnia 93.7% (89), problems in activity or sexual
arousal 89.5% (85), feeling tired 86.3% (82), lack of appetite 81.1% (77), dizziness 80%
(76), irritability 80% (76), pain 78.9% (75), lack of energy 78, 9 (75). From the total score
of all symptoms obtained an average symptom of 1.08 (± 0.386) with a minimum value
of 0.61 and a maximum of 2.06.
4. Discussion
Ten common symptoms experienced by respondents with gynecological cancer were
feeling worried, feeling sad, insomnia, problems in activity or sexual arousal, feeling
tired, lack of appetite, dizziness, irritability, pain and less energy. As research conducted
by Harrington, Hansen and Moskowitz (2010), that women with gynecological cancer
have a burden of symptoms from time to time, some data indicate that fatigue, cognitive
limitations, depression, anxiety, sleep problems, pain and difficulty having sex which
takes place during the treatment process[6]. Symptoms are more severe in patients
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who receive active cancer treatment and the prevalence of symptoms increases with
an increase in the stage of the disease in gynecological cancers.
Some researchers have also reported specific emotional reactions to women with
gynecological cancer, and have found that the burden of psychological stress is a
common problem. Emotions that can be caused such as symptoms of depression due
to life uncertainty and doubts about the future, anxiety, confusion, anger due to loss
of reproductive function and opportunities to have children, feelings of guilt due to
disrupted sexual activity [9]. In the study of Cleeland & Reyyes (2002), symptoms can
originate from the disease itself or due to treatment / treatment of an illness [10]. In
previous study, patients said the impact of living with severe symptoms in their definition
was ”burden of symptoms”[11]. They talked about the effect that uncontrolled symptoms
have a function and the amount of emotion from severe symptoms. Patients state that
they have special concerns about the death / progression of the disease.
5. Conclusion
Indicated that psychological symptoms is the common symptom that experienced
by women with gynecological cancer. Nursing and other healthcare professional is
expected to pay more attention to psychological symptoms to meets the need of
patient.
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